NCT02428192
- Conditions
- Leiomyosarcoma, Metastatic Leiomyosarcoma, Neoplasms, +6 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Uterine Corpus Leiomyosarcoma
Explore clinical trials studying Uterine Corpus Leiomyosarcoma. Study availability and eligibility vary by location and protocol.
7 public trials
0 recruiting studies
Uterine Corpus Leiomyosarcoma trial results
NCT01220609
- Conditions
- Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma
- Locations
-
- Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Los Angeles County-USC Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT00025220
- Conditions
- Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
NCT01637961
- Conditions
- Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma
- Locations
-
- Hartford Hospital Hartford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States
- The Hospital of Central Connecticut New Britain, Connecticut, United States
- Florida Hospital Orlando Orlando, Florida, United States
NCT00031629
- Conditions
- Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma
- Locations
-
- Gynecologic Oncology Group Philadelphia, Pennsylvania, United States
NCT00897442
- Conditions
- Adenoma, Adnexal Diseases, Borderline Ovarian Clear Cell Tumor, +143 more
- Locations
-
- Highlands Oncology Group PA - Fayetteville Fayetteville, Arkansas, United States
- Washington Regional Medical Center - Fayetteville Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
Active, Not Recruiting
A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma
NCT03880019
- Conditions
- Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8, Uterine Corpus Leiomyosarcoma
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
- UF Health Cancer Institute - Gainesville Gainesville, Florida, United States